Boston Scientific Hit by Cyberattack: Shares Fall 5.8%

Boston Scientific, a leading manufacturer of critical medical devices such as pacemakers and stents, has been targeted by a cyberattack. The company's shares fell 5.8% following the news of the attack, reflecting investor concerns. The attack is expected to disrupt the company's order and shipping systems. This could lead to delays in the medical device supply chain and negatively impact Boston Scientific's operational performance in the short term. Experts note that cyberattacks on the healthcare sector pose a growing threat. The measures Boston Scientific takes in response to this attack and how quickly it can recover its systems will be decisive for the company's market value. Company officials have not yet provided detailed information about the scope and impact of the attack. As investors closely monitor developments, volatility in the stock price is expected to continue. This is not investment advice.